Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 18 Sept 2026 for CRESCENT BIOPHARMA, INC., €9,667.
Filing timeline
BuySaleEllie Eunkyung Im
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Ellie Eunkyung Im: trading record in brief
Ellie Eunkyung Im appears in our data through filings on Crescent Biopharma, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 15 December 2025 to 16 September 2026.
Every open-market trade on record is a sale: 2 sales worth €29k. Other entries cover 2 share grants. Since January 2026: no purchases and 2 sales on the market.
The record was last updated on 18 September 2026 with an open-market sale (€9,667) in Crescent Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ellie Eunkyung Im
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
623 shares@ US$17.90Ordinary SharesSEC:0001628280-26-062706:0
1,219 sharesOrdinary SharesSEC:0001628280-26-044886:0
16,298 sharesOrdinary SharesSEC:0001628280-25-057673:0
3 of 3 declarations
